In a colon carcinoma model, endogenous IL-33 promoted IFN-γ expression by both CD4+ and CD8+ T cells, increased CD8+ T cell infiltration over Treg cells and augmented CD8+ T cell-mediated antitumor responses (30). The gene discussed is IL33; the disease is colon carcinoma.